These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

736 related items for PubMed ID: 25312783

  • 1. Triple immunosuppressive therapy in steroid-resistant nephrotic syndrome children with tacrolimus resistance or tacrolimus sensitivity but frequently relapsing.
    Wu B, Mao J, Shen H, Fu H, Wang J, Liu A, Gu W, Shu Q, Du L.
    Nephrology (Carlton); 2015 Jan; 20(1):18-24. PubMed ID: 25312783
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of mycophenolate mofetil or tacrolimus in children with steroid sensitive but frequently relapsing or steroid-dependent nephrotic syndrome.
    Wang J, Mao J, Chen J, Fu H, Shen H, Zhu X, Liu A, Shu Q, Du L.
    Nephrology (Carlton); 2016 Jan; 21(1):21-7. PubMed ID: 26697959
    [Abstract] [Full Text] [Related]

  • 3. Mycophenolate mofetil is inferior to tacrolimus in sustaining remission in children with idiopathic steroid-resistant nephrotic syndrome.
    Sinha A, Gupta A, Kalaivani M, Hari P, Dinda AK, Bagga A.
    Kidney Int; 2017 Jul; 92(1):248-257. PubMed ID: 28318625
    [Abstract] [Full Text] [Related]

  • 4. Interventions for idiopathic steroid-resistant nephrotic syndrome in children.
    Hodson EM, Wong SC, Willis NS, Craig JC.
    Cochrane Database Syst Rev; 2016 Oct 11; 10(10):CD003594. PubMed ID: 27726125
    [Abstract] [Full Text] [Related]

  • 5. Mycophenolate mofetil for sustained remission in nephrotic syndrome.
    Querfeld U, Weber LT.
    Pediatr Nephrol; 2018 Dec 11; 33(12):2253-2265. PubMed ID: 29750317
    [Abstract] [Full Text] [Related]

  • 6. Mycophenolate mofetil therapy for steroid-resistant IgA nephropathy with the nephrotic syndrome in children.
    Kang Z, Li Z, Duan C, Wu T, Xun M, Ding Y, Zhang Y, Zhang L, Yin Y.
    Pediatr Nephrol; 2015 Jul 11; 30(7):1121-9. PubMed ID: 25773534
    [Abstract] [Full Text] [Related]

  • 7. Treatment with tacrolimus and prednisolone is preferable to intravenous cyclophosphamide as the initial therapy for children with steroid-resistant nephrotic syndrome.
    Gulati A, Sinha A, Gupta A, Kanitkar M, Sreenivas V, Sharma J, Mantan M, Agarwal I, Dinda AK, Hari P, Bagga A.
    Kidney Int; 2012 Nov 11; 82(10):1130-5. PubMed ID: 22763815
    [Abstract] [Full Text] [Related]

  • 8. Tacrolimus versus intravenous pulse cyclophosphamide therapy in Chinese adults with steroid-resistant idiopathic minimal change nephropathy: a multicenter, open-label, nonrandomized cohort trial.
    Li H, Shi X, Shen H, Li X, Wang H, Li H, Xu G, Chen J.
    Clin Ther; 2012 May 11; 34(5):1112-20. PubMed ID: 22503105
    [Abstract] [Full Text] [Related]

  • 9. The efficacy and safety of tacrolimus monotherapy in adult-onset nephrotic syndrome caused by idiopathic membranous nephropathy.
    Liang Q, Li H, Xie X, Qu F, Li X, Chen J.
    Ren Fail; 2017 Nov 11; 39(1):512-518. PubMed ID: 28562168
    [Abstract] [Full Text] [Related]

  • 10. [Mycophenolate mofetil in treatment of childhood nephrotic syndrome--preliminary report].
    Kwinta-Rybicka J, Wilkosz K, Wierzchowska-Słowiacze EK, Ogarek I, Moczulska A, Stec Z, Pełkowska A, Sancewicz-Pach K, Pietrzyk JA.
    Przegl Lek; 2006 Nov 11; 63 Suppl 3():44-8. PubMed ID: 16898486
    [Abstract] [Full Text] [Related]

  • 11. [Mycophenolate mofetil (MMF) as the first choice immunosuppressive drug in treatment of steroid-dependent nephrotic syndrome in children].
    Ogarek I, Szczęsny-Choruz E, Wierzchowska-Słowiaczek E, Kwinta-Rybicka J, Stec Z, Moczulska A, Wilkosz K, Drożdż D.
    Pol Merkur Lekarski; 2018 Apr 23; 44(262):192-195. PubMed ID: 29775447
    [Abstract] [Full Text] [Related]

  • 12. Study protocol: mycophenolate mofetil as maintenance therapy after rituximab treatment for childhood-onset, complicated, frequently-relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicenter double-blind, randomized, placebo-controlled trial (JSKDC07).
    Horinouchi T, Sako M, Nakanishi K, Ishikura K, Ito S, Nakamura H, Oba MS, Nozu K, Iijima K.
    BMC Nephrol; 2018 Nov 01; 19(1):302. PubMed ID: 30382824
    [Abstract] [Full Text] [Related]

  • 13. Mycophenolate mofetil in steroid/cyclosporine-dependent/resistant nephrotic syndrome.
    Mendizábal S, Zamora I, Berbel O, Sanahuja MJ, Fuentes J, Simon J.
    Pediatr Nephrol; 2005 Jul 01; 20(7):914-9. PubMed ID: 15891923
    [Abstract] [Full Text] [Related]

  • 14. Long-term efficacy and safety of common steroid-sparing agents in idiopathic nephrotic children.
    Basu B, Babu BG, Mahapatra TK.
    Clin Exp Nephrol; 2017 Feb 01; 21(1):143-151. PubMed ID: 27108294
    [Abstract] [Full Text] [Related]

  • 15. Mycophenolate mofetil and prednisolone therapy in children with steroid-dependent nephrotic syndrome.
    Bagga A, Hari P, Moudgil A, Jordan SC.
    Am J Kidney Dis; 2003 Dec 01; 42(6):1114-20. PubMed ID: 14655181
    [Abstract] [Full Text] [Related]

  • 16. A comparison of a standard-dose prednisone regimen and mycophenolate mofetil combined with a lower prednisone dose in Chinese adults with idiopathic nephrotic syndrome who were carriers of hepatitis B surface antigen: a prospective cohort study.
    Li X, Tian J, Wu J, He Q, Li H, Han F, Li Q, Chen Y, Ni Q, Chen J.
    Clin Ther; 2009 Apr 01; 31(4):741-50. PubMed ID: 19446147
    [Abstract] [Full Text] [Related]

  • 17. [A prospective multicenter clinical control trial on treatment of refractory nephrotic syndrome with mycophenolate mofetil in children].
    Yi ZW, Wu XC, Xu H, Zhou LJ, Wu YB, Feng SP, Zhou JH, Yang Q, Zhu GH, Liu AM, Wei MJ, Yu L, Zeng ZF.
    Zhongguo Dang Dai Er Ke Za Zhi; 2008 Oct 01; 10(5):575-8. PubMed ID: 18947472
    [Abstract] [Full Text] [Related]

  • 18. Tacrolimus can induce remission in cyclosporine and mycophenolate mofetil resistant pediatric onset nephrotic syndrome.
    Ahmed HM.
    Iran J Kidney Dis; 2019 Sep 01; 13(5):322-327. PubMed ID: 31705749
    [Abstract] [Full Text] [Related]

  • 19. Tacrolimus: a new therapy for steroid-resistant nephrotic syndrome in children.
    Gulati S, Prasad N, Sharma RK, Kumar A, Gupta A, Baburaj VP.
    Nephrol Dial Transplant; 2008 Mar 01; 23(3):910-3. PubMed ID: 18039644
    [Abstract] [Full Text] [Related]

  • 20. Remission of relapsing childhood nephrotic syndrome with mycophenolate mofetil.
    Chandra M, Susin M, Abitbol C.
    Pediatr Nephrol; 2000 Mar 01; 14(3):224-6. PubMed ID: 10752763
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.